Uterine arteriovenous malformations (AVM) are a rare entity, presenting in women of reproductive age. The presentation may vary with bleeding being the chief presenting symptom. Though traditionally hysterectomy has been a definitive form of treatment, trans-catheter embolization is being considered as a good treatment option. We present three cases with uterine AVM who presented with heavy bleeding per vaginam. Three patients of reproductive age group (29-33 years) presented with heavy bleeding per vaginam from January 2017- May 2017. Two had previous miscarriages for which curettage was done and one had undergone a Caesarean section previously. Diagnosis of uterine AVM was made by ultrasound-grey scale, colour Doppler, followed by MRI. All patients underwent trans-catheter angiogram followed by selective embolization of the AVM with n-BCA (n- Butyl Cyanoacrylate) and polyvinyl alcohol (PVA) particles. Successful embolization was done in all of our patients with technical success rate of 100%. On follow-up, all patients are currently asymptomatic. Trans-catheter arterial embolization of uterine AVM is a simple and effective treatment alternative with less morbidity associated with anaesthesia and surgery in turn reducing hospital stay. It has to be considered in patients who need to preserve their fertility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.